Showing results (661-670 of 1,167) with videos related to

Sort By:
Pageof 117
Plos One|August 14, 2013
Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resectionYong-Sheng Xiao, Qiang Gao, Xiang-Nan Xu, et al.
Frontiers in Immunology|March 13, 2023
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapyDe-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinomaQiang Gao, Xiao-Ying Wang, Shuang-Jian Qiu, et al.
World Journal of Gastroenterology|August 31, 2004
Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control studyZheng-Gang Ren, Zhi-Ying Lin, Jing-Lin Xia, et al.
Cancer Letters|October 25, 2017
MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinomaXiu-Tao Fu, Ying-Hong Shi, Jian Zhou, et al.
Journal of Gastroenterology and Hepatology|October 5, 2017
Multimodality treatment of hepatocellular carcinomaZhao-You Tang, Xin-DA Zhou, Zeng-Chen Ma, et al.
Neurocase|April 6, 2017
Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer's diseaseLuke W Bonham, Daniel W Sirkis, Jia Fan, et al.
Annals of Translational Medicine|November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteriaDe-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
Journal of Hepatology|February 1, 2025
Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunityZefan Zhang, Chenlu Geng, Minfang Song, et al.
Cancer Letters|June 6, 2023
WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomasWei-Yu Han, Jie Wang, Jing Zhao, et al.
Pageof 117